business

S.biomedic’s autologous fibroblast therapy, Cureskin, received KFDA approval in year 2010. The Cureskin is a subcutaneous injection of 2x107cells/ml. It is mainly
used for depressed acne scars and improvement of facial wrinkles.

Autologous Dermal Fibroblast
Indication: Depressed Acne Scar
Intra-dermal injection
Dose: 2×107 cells/ml
Usage: 3times injection, biweekly


Conditioned Culture Media Cosmetic
Cosmetic product containing various growth factors
(EGF, VEGF, FGF, HGF, PDGF, etc) and fibroblast
conditioned media which are responsible for skin
elasticity and whitening.